FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149678323> ?p ?o ?g. }

• W2149678323 endingPage "725" @default.
• W2149678323 startingPage "719" @default.
• W2149678323 abstract "Interindividual variation in the ability of aspirin to inhibit platelet cyclooxygenase-1 (COX-1) could account for some on-treatment cardiovascular events. Here, we sought to determine whether there are clinical phenotypes that are associated with a suboptimal pharmacological effect of aspirin. In a prospective, 2-week study, we evaluated the effect of aspirin (81 mg) on platelet COX-1 in 135 patients with stable coronary artery disease by measuring serum thromboxane B 2 (sTxB 2 ) as an indicator of inhibition of platelet COX-1. A nested randomized study compared enteric-coated with immediate-release formulations of aspirin. We found that sTxB 2 was systematically higher among the 83 patients with metabolic syndrome than among the 52 patients without (median: 4.0 versus 3.02 ng/mL; P =0.013). Twelve patients (14%) with metabolic syndrome, but none without metabolic syndrome, had sTxB 2 levels consistent with inadequate inhibition of COX (sTxB 2 ≥13 ng/mL). In linear regression models, metabolic syndrome (but none of its individual components) significantly associated with higher levels of log-transformed sTxB 2 ( P =0.006). Higher levels of sTxB 2 associated with greater residual platelet function measured by aggregometry-based methods. Among the randomized subset, sTxB 2 levels were systematically higher among patients receiving enteric-coated aspirin. Last, urinary 11-dehydro thromboxane B 2 did not correlate with sTxB 2 , suggesting that the former should not be used to quantitate aspirin's pharmacological effect on platelets. In conclusion, metabolic syndrome, which places patients at high risk for thrombotic cardiovascular events, strongly and uniquely associates with less effective inhibition of platelet COX-1 by aspirin." @default.
• W2149678323 created "2016-06-24" @default.
• W2149678323 creator A5000277265 @default.
• W2149678323 creator A5003520454 @default.
• W2149678323 creator A5011155701 @default.
• W2149678323 creator A5026806093 @default.
• W2149678323 creator A5044428046 @default.
• W2149678323 creator A5048405646 @default.
• W2149678323 creator A5061583198 @default.
• W2149678323 creator A5075984448 @default.
• W2149678323 date "2012-03-01" @default.
• W2149678323 modified "2023-09-30" @default.
• W2149678323 title "Suboptimal Inhibition of Platelet Cyclooxygenase-1 by Aspirin in Metabolic Syndrome" @default.
• W2149678323 cites W1544326688 @default.
• W2149678323 cites W1966562996 @default.
• W2149678323 cites W1967639757 @default.
• W2149678323 cites W1969187957 @default.
• W2149678323 cites W1971720175 @default.
• W2149678323 cites W1981260144 @default.
• W2149678323 cites W1983380547 @default.
• W2149678323 cites W1984403197 @default.
• W2149678323 cites W1988143463 @default.
• W2149678323 cites W2014644245 @default.
• W2149678323 cites W2019823845 @default.
• W2149678323 cites W2023684680 @default.
• W2149678323 cites W2024237851 @default.
• W2149678323 cites W2024352468 @default.
• W2149678323 cites W2030087792 @default.
• W2149678323 cites W2033182048 @default.
• W2149678323 cites W2042568518 @default.
• W2149678323 cites W2045934073 @default.
• W2149678323 cites W2050820265 @default.
• W2149678323 cites W2052751204 @default.
• W2149678323 cites W2054008451 @default.
• W2149678323 cites W2059064084 @default.
• W2149678323 cites W2060641563 @default.
• W2149678323 cites W2065470468 @default.
• W2149678323 cites W2091689060 @default.
• W2149678323 cites W2095345740 @default.
• W2149678323 cites W2095583390 @default.
• W2149678323 cites W2097657831 @default.
• W2149678323 cites W2100089051 @default.
• W2149678323 cites W2100858861 @default.
• W2149678323 cites W2103714496 @default.
• W2149678323 cites W2104805509 @default.
• W2149678323 cites W2108552275 @default.
• W2149678323 cites W2112357684 @default.
• W2149678323 cites W2125921020 @default.
• W2149678323 cites W2125996164 @default.
• W2149678323 cites W2131398405 @default.
• W2149678323 cites W2145624961 @default.
• W2149678323 cites W2147195562 @default.
• W2149678323 cites W2161043271 @default.
• W2149678323 cites W2166196321 @default.
• W2149678323 cites W3169105340 @default.
• W2149678323 cites W4244537139 @default.
• W2149678323 cites W74340591 @default.
• W2149678323 doi "https://doi.org/10.1161/hypertensionaha.111.181404" @default.
• W2149678323 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3418792" @default.
• W2149678323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22311905" @default.
• W2149678323 hasPublicationYear "2012" @default.
• W2149678323 type Work @default.
• W2149678323 sameAs 2149678323 @default.
• W2149678323 citedByCount "47" @default.
• W2149678323 countsByYear W21496783232012 @default.
• W2149678323 countsByYear W21496783232013 @default.
• W2149678323 countsByYear W21496783232014 @default.
• W2149678323 countsByYear W21496783232015 @default.
• W2149678323 countsByYear W21496783232016 @default.
• W2149678323 countsByYear W21496783232017 @default.
• W2149678323 countsByYear W21496783232018 @default.
• W2149678323 countsByYear W21496783232019 @default.
• W2149678323 countsByYear W21496783232020 @default.
• W2149678323 countsByYear W21496783232021 @default.
• W2149678323 countsByYear W21496783232022 @default.
• W2149678323 countsByYear W21496783232023 @default.
• W2149678323 crossrefType "journal-article" @default.
• W2149678323 hasAuthorship W2149678323A5000277265 @default.
• W2149678323 hasAuthorship W2149678323A5003520454 @default.
• W2149678323 hasAuthorship W2149678323A5011155701 @default.
• W2149678323 hasAuthorship W2149678323A5026806093 @default.
• W2149678323 hasAuthorship W2149678323A5044428046 @default.
• W2149678323 hasAuthorship W2149678323A5048405646 @default.
• W2149678323 hasAuthorship W2149678323A5061583198 @default.
• W2149678323 hasAuthorship W2149678323A5075984448 @default.
• W2149678323 hasBestOaLocation W21496783231 @default.
• W2149678323 hasConcept C126322002 @default.
• W2149678323 hasConcept C134018914 @default.
• W2149678323 hasConcept C181199279 @default.
• W2149678323 hasConcept C2776785769 @default.
• W2149678323 hasConcept C2777628954 @default.
• W2149678323 hasConcept C2779689624 @default.
• W2149678323 hasConcept C2780578515 @default.
• W2149678323 hasConcept C2781024287 @default.
• W2149678323 hasConcept C2781080829 @default.
• W2149678323 hasConcept C3018697912 @default.
• W2149678323 hasConcept C511355011 @default.
• W2149678323 hasConcept C55493867 @default.

• next